Published • loading... • Updated
OpenAI Starts Offering a Biology-Tuned LLM
The biology-tuned model is designed to synthesize evidence, generate hypotheses and plan experiments, with a research preview limited to qualified U.S. enterprises.
Summary by Ars Technica
3 Articles
3 Articles
OpenAI debuts GPT-Rosalind, a new limited access model for life sciences, and broader Codex plugin on Github
The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and billions of dollars in investment. Progress is often stymied not just by the inherent mysteries of biology, but by the "fragmented and difficult to scale" workflows that force researchers to manually pivot between the actual experimental design equipment, software, and databases.But OpenAI i…
·San Francisco, United States
Read Full ArticleOpenAI debuts a life sciences AI model, entering crowd of tech giants selling to pharma
OpenAI is the latest tech giant to move into biopharma, announcing a life sciences-focused AI offering on Thursday. The San Francisco-based company announced GPT-Rosalind, effectively a version of ChatGPT tailored to the specialized work of ...
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium

